Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.
about
Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinomaValidation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature PigsUrokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients.Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area.Validation of an IGF-CTP scoring system for assessing hepatic reserve in Egyptian patients with hepatocellular carcinomaObesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma.Systematic tracking of disrupted modules identifies significant genes and pathways in hepatocellular carcinoma.Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma.Serum insulin-like growth factor-1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: a systematic review and meta-analysis.
P2860
Q26784218-030F4029-3C21-4CF6-9F3A-EB8D4B6DA55CQ28080514-67F1AE5C-E180-4205-AA39-9D455DFE3B31Q33688431-71DCBCCA-61D0-48E8-A188-FBB6A1FEFD46Q35672369-352E9266-537E-4FC8-998A-CE1138E63795Q36255571-02D23E85-85F9-49B1-9381-4BE08E2608CEQ36356282-A94321D8-CC33-4E48-B6FA-6BB866FD079EQ36652018-1D53B656-66F5-4ADB-993D-B83F3EE6FB13Q37406913-66F49253-D6A9-479D-B1BD-395179CA063CQ38910274-DBD82200-DA93-4FE1-BF45-D47DAD3B5E9CQ47117659-43A41B40-056A-4D8F-993F-1131C796C0B7
P2860
Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Development and validation of ...... e in hepatocellular carcinoma.
@ast
Development and validation of ...... e in hepatocellular carcinoma.
@en
type
label
Development and validation of ...... e in hepatocellular carcinoma.
@ast
Development and validation of ...... e in hepatocellular carcinoma.
@en
prefLabel
Development and validation of ...... e in hepatocellular carcinoma.
@ast
Development and validation of ...... e in hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Development and validation of ...... e in hepatocellular carcinoma.
@en
P2093
Ahmed O Kaseb
Asif Rashid
Claudius Conrad
Hesham M Hassabo
James L Abbruzzese
Jeffrey S Morris
John M Vierling
Ju-Seog Lee
Kanwal Raghav
Lianchun Xiao
P2860
P356
10.1093/JNCI/DJU088
P407
P577
2014-05-09T00:00:00Z